Recall events
/
Event 82554
Event summary
Timeline bucket April 02, 2019
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
68 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 68
Acetylcysteine 10% Ophthalmic Eye Drop 2 mL droptainer, Anderson Compounding Pharmacy 310 Bluff City Hwy Bristol, TN.
D-1137-2019
Recall number D-1137-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 10 drop containers
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4550]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 68
Atropine 0.01% Eye Drops, 1 mL and 2 mL Dropper, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1138-2019
Recall number D-1138-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity Unknown
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4569]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 68
Amphotericin B 0.15% Eye Drops, 2 mL Droppers, Anderson Compounding Pharmacy 310 Bluff City Hwy Bristol, TN.
D-1139-2019
Recall number D-1139-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 5 drop containers
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4567]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 68
Vancomycin 125 mg/3mL Inhalation, 3 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1140-2019
Recall number D-1140-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11173]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 68
Dexamethasone 24 mg/mL Injection, 10 mL Vial, Anderson Compounding Pharmacy, 310 Bluff City Hwy, Bristol, TN.
D-1141-2019
Recall number D-1141-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 3 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4596]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 68
DMSO 50% 60 mL/Heparin 1 mL/ Sodium Bicarbonate 60 mL/ Solu-Cortef 100 mg, 41 mL syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1142-2019
Recall number D-1142-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 1 syringe
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4440]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 68
Estradiol Cypionate 10 mg/mL, 5 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1143-2019
Recall number D-1143-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 35 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4555]
FDA event record
· Exact recall-number query on openFDA
drug · product 8 of 68
Gentamicin 120 mg/250 mL 0.9% Sodium Chloride for Irrigation, 30 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1144-2019
Recall number D-1144-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 6 syringes
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4598]
FDA event record
· Exact recall-number query on openFDA
drug · product 9 of 68
Gentamicin 250 mg/1000 mL Irrigation, 1000 mL, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1145-2019
Recall number D-1145-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 4 bottles
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4553]
FDA event record
· Exact recall-number query on openFDA
drug · product 10 of 68
HCG 1,000 U/mL Injection, 30 mL, Vial Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1146-2019
Recall number D-1146-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4634]
FDA event record
· Exact recall-number query on openFDA
drug · product 11 of 68
HCG 11,000 Units, 30 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1147-2019
Recall number D-1147-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 9 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4663]
FDA event record
· Exact recall-number query on openFDA
drug · product 12 of 68
HCG 20 Day Injection, 2625 Units/4 mL, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1148-2019
Recall number D-1148-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 217 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4633]
FDA event record
· Exact recall-number query on openFDA
drug · product 13 of 68
HCG 23 Day, 2876 Units/4.6 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1149-2019
Recall number D-1149-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 31 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4559]
FDA event record
· Exact recall-number query on openFDA
drug · product 14 of 68
HCG 30 Day, 3750 Units/6 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN 1-800-263-8890
D-1150-2019
Recall number D-1150-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 57 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4665]
FDA event record
· Exact recall-number query on openFDA
drug · product 15 of 68
HCG 20 Day Extra Strength, 3500 Units/4 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1151-2019
Recall number D-1151-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 99 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4565]
FDA event record
· Exact recall-number query on openFDA
drug · product 16 of 68
HCG 20,000 units/vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1152-2019
Recall number D-1152-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4600]
FDA event record
· Exact recall-number query on openFDA
drug · product 17 of 68
HCG 23 Day Injection Extra Strength, vials, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN 1-800-263-8890
D-1153-2019
Recall number D-1153-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 14 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4541]
FDA event record
· Exact recall-number query on openFDA
drug · product 18 of 68
HCG 4,100 Units/vial Injection, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1154-2019
Recall number D-1154-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4660]
FDA event record
· Exact recall-number query on openFDA
drug · product 19 of 68
HCG 40 Day Injection Extra Strength, vials, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1155-2019
Recall number D-1155-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4542]
FDA event record
· Exact recall-number query on openFDA
drug · product 20 of 68
Heparin 20,000 U/Lidocaine 2% 10 mL/Sodium Bicarbonate 8.4% 10 mL/Sterile Water 5 mL, 27 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1156-2019
Recall number D-1156-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 2 syringes
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4625]
FDA event record
· Exact recall-number query on openFDA
drug · product 21 of 68
Heparin 10 mL/ Marcain 0.25% 20 mL/Sodium Bicarbonate 8.4%-40 mL/ Normal Saline 5 mL, 60 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1157-2019
Recall number D-1157-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 1 syringe
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4546]
FDA event record
· Exact recall-number query on openFDA
drug · product 22 of 68
Heparin 10,000 U/Bupivacaine 0.5% 10 mL, Sodium Bicarbonate 8.4% 50 mL, 61 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1158-2019
Recall number D-1158-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 1 syringe
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4639]
FDA event record
· Exact recall-number query on openFDA
drug · product 23 of 68
Heparin 10 mL/Marcain 0.25% 20 mL/Sodium Bicarbonate 8.4%-40 mL/per 70 mL, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1159-2019
Recall number D-1159-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 12 syringes
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4537]
FDA event record
· Exact recall-number query on openFDA
drug · product 24 of 68
Heparin 2 mL/Lidocaine 2%-10 mL/Sodium Bicarbonate 8.4%-5mL/ Sterile Water 10 mL, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1160-2019
Recall number D-1160-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 6 syringes
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4533]
FDA event record
· Exact recall-number query on openFDA
drug · product 25 of 68
Methionine 15mg/Choline 100mg/ Inositol 50mg/ Methylcobalamin 1mg/ Lidocoaine 10 mg, benzyl alcohol/ water, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1161-2019
Recall number D-1161-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 276 vails
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4444]
FDA event record
· Exact recall-number query on openFDA
drug · product 26 of 68
Methylcobalamin 1 mg/mL Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1162-2019
Recall number D-1162-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 5 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4445]
FDA event record
· Exact recall-number query on openFDA
drug · product 27 of 68
Methylprednisolone 1% PF Ophthalmic, 3 mL Droppers, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1163-2019
Recall number D-1163-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 5 drop containers
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4635]
FDA event record
· Exact recall-number query on openFDA
drug · product 28 of 68
Morphine Sulfate 5 mg/3mL Inhalation, 3 mL Vials, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1164-2019
Recall number D-1164-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 60 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4483]
FDA event record
· Exact recall-number query on openFDA
drug · product 29 of 68
Penicillin G 100,000/mL 10 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1165-2019
Recall number D-1165-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4557]
FDA event record
· Exact recall-number query on openFDA
drug · product 30 of 68
Phenylephrine 1 mg/mL Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1166-2019
Recall number D-1166-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 1 vial
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4560]
FDA event record
· Exact recall-number query on openFDA
drug · product 31 of 68
Polyhexamethylene Biguanide 0.02% Ophthalmic Drops, 2 mL Dropper, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1167-2019
Recall number D-1167-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 5 drop containers
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4637]
FDA event record
· Exact recall-number query on openFDA
drug · product 32 of 68
Prostaglandin 20 mcg/mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1168-2019
Recall number D-1168-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 23 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4668]
FDA event record
· Exact recall-number query on openFDA
drug · product 33 of 68
Prostaglandin 40 mcg/mL, Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1169-2019
Recall number D-1169-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 6 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4484]
FDA event record
· Exact recall-number query on openFDA
drug · product 34 of 68
Prostaglandin 60 mcg/mL, Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1170-2019
Recall number D-1170-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 5 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4446]
FDA event record
· Exact recall-number query on openFDA
drug · product 35 of 68
Prostaglandin Quad-Mix 20:30:1:0.15 Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1171-2019
Recall number D-1171-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 40 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4485]
FDA event record
· Exact recall-number query on openFDA
drug · product 36 of 68
Prostaglandin Quad with Atropine 10:30:1:0.15, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1172-2019
Recall number D-1172-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 5 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4564]
FDA event record
· Exact recall-number query on openFDA
drug · product 37 of 68
Prostaglandin Tri-Mix 20:30:1, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1173-2019
Recall number D-1173-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 58 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4547]
FDA event record
· Exact recall-number query on openFDA
drug · product 38 of 68
Prostaglandin Tri-Mix 50:30:1, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1174-2019
Recall number D-1174-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 31 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4568]
FDA event record
· Exact recall-number query on openFDA
drug · product 39 of 68
Sermorelin 0.3 mg/0.5 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1175-2019
Recall number D-1175-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 22 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4442]
FDA event record
· Exact recall-number query on openFDA
drug · product 40 of 68
Sermorelin 0.4 mg/0.5 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1176-2019
Recall number D-1176-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 6 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4443]
FDA event record
· Exact recall-number query on openFDA
drug · product 41 of 68
Serum Tears 20% Drops, 1 mL Droptainer, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1177-2019
Recall number D-1177-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 40 drop containers
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4629]
FDA event record
· Exact recall-number query on openFDA
drug · product 42 of 68
Serum Tears 30% Drops, 1 mL Droptainer, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1178-2019
Recall number D-1178-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 60 drop containers
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4666]
FDA event record
· Exact recall-number query on openFDA
drug · product 43 of 68
Streptomycin 24 mg/Dexamethasone 10 mg/mL Otic Injection, 1 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1179-2019
Recall number D-1179-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 10 syringes
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4632]
FDA event record
· Exact recall-number query on openFDA
drug · product 44 of 68
Bacitracin 3000U/30 mL Irrigation, 30 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1180-2019
Recall number D-1180-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 2 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4551]
FDA event record
· Exact recall-number query on openFDA
drug · product 45 of 68
Testosterone Cypionate 250 mg/mL Sterile Injection, 5 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1181-2019
Recall number D-1181-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 5 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4543]
FDA event record
· Exact recall-number query on openFDA
drug · product 46 of 68
Vitamin D3 200,000 IU/mL Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1182-2019
Recall number D-1182-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity 4 vials
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4540]
FDA event record
· Exact recall-number query on openFDA
drug · product 47 of 68
Methylcobalamin 3000 mcg/mL Injection Solution, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1183-2019
Recall number D-1183-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11155]
FDA event record
· Exact recall-number query on openFDA
drug · product 48 of 68
Serum Tears 50% Ophthalmic Drops, 1 mL Dropper, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1184-2019
Recall number D-1184-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11153]
FDA event record
· Exact recall-number query on openFDA
drug · product 49 of 68
Interferon 1 Million IU/mL Eye Drops, 1 mL Droptainer, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1185-2019
Recall number D-1185-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11170]
FDA event record
· Exact recall-number query on openFDA
drug · product 50 of 68
Prostaglandin Tri-Mix 60:30:1 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1186-2019
Recall number D-1186-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11078]
FDA event record
· Exact recall-number query on openFDA
drug · product 51 of 68
Neomycin 40 mg/Polymixin B 200,000 Bladder Irrigation Solution, 1000 mL bottle, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1187-2019
Recall number D-1187-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[10823]
FDA event record
· Exact recall-number query on openFDA
drug · product 52 of 68
Lidocaine 1%/Dextrose 12.5% (PF) Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1188-2019
Recall number D-1188-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11175]
FDA event record
· Exact recall-number query on openFDA
drug · product 53 of 68
EDTA 1% Sterile Injection (Preservative Free), Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1189-2019
Recall number D-1189-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11166]
FDA event record
· Exact recall-number query on openFDA
drug · product 54 of 68
Sodium Bicarbonate 8.4% Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1190-2019
Recall number D-1190-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[10791]
FDA event record
· Exact recall-number query on openFDA
drug · product 55 of 68
Heparin 20,000U/Marcaine 0.25%, 10 mL, Sodium Bicarbonate 8.4% 48 mL, 60 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1191-2019
Recall number D-1191-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11075]
FDA event record
· Exact recall-number query on openFDA
drug · product 56 of 68
Gentamicin 160 mg/1000 mL Sterile Water for Irrigation,1000 mL Bottle, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1192-2019
Recall number D-1192-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11157]
FDA event record
· Exact recall-number query on openFDA
drug · product 57 of 68
Gentamicin 240 mg/500 mL Sterile Water for Irrigation,60 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1193-2019
Recall number D-1193-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[10496]
FDA event record
· Exact recall-number query on openFDA
drug · product 58 of 68
Heparin 10 mL/Marcaine 0.25% 20 mL/Sodium Bicarbonate 40 mL/Normal Saline 5 mL per 75 mL, 60 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1194-2019
Recall number D-1194-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11069]
FDA event record
· Exact recall-number query on openFDA
drug · product 59 of 68
Estrone 5mg/mL Oil Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1195-2019
Recall number D-1195-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11073]
FDA event record
· Exact recall-number query on openFDA
drug · product 60 of 68
HCG 11,00Units/B 12 11,000 mcg Injection, 30 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1196-2019
Recall number D-1196-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11086]
FDA event record
· Exact recall-number query on openFDA
drug · product 61 of 68
Papaverine 30 mg/Phentolamine 0.5 mg/mL, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1197-2019
Recall number D-1197-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11291]
FDA event record
· Exact recall-number query on openFDA
drug · product 62 of 68
Papaverine 30 mg/mL Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1198-2019
Recall number D-1198-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11112]
FDA event record
· Exact recall-number query on openFDA
drug · product 63 of 68
Phenol 10% Injection, 5 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1199-2019
Recall number D-1199-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[10848]
FDA event record
· Exact recall-number query on openFDA
drug · product 64 of 68
Prostaglandin Tri-Mix 5:15:0.5 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1200-2019
Recall number D-1200-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11063]
FDA event record
· Exact recall-number query on openFDA
drug · product 65 of 68
Prostaglandin Tri-Mix 2.5:7.5:0.25 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1201-2019
Recall number D-1201-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11041]
FDA event record
· Exact recall-number query on openFDA
drug · product 66 of 68
Prostaglandin Tri-Mix 8.33:22.5:0.833 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1202-2019
Recall number D-1202-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11181]
FDA event record
· Exact recall-number query on openFDA
drug · product 67 of 68
Prostaglandin Tri-Mix 20:25:1 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1203-2019
Recall number D-1203-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11150]
FDA event record
· Exact recall-number query on openFDA
drug · product 68 of 68
Prostaglandin Tri-Mix 30:30:1 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
D-1204-2019
Recall number D-1204-2019
Initiated April 02, 2019
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[11294]
FDA event record
· Exact recall-number query on openFDA
